BHA & BHT: The Antioxidants Keeping Your Cereal Fresh — and the Cancer Question That Won't Go Away

What BHA and BHT are

BHA — butylated hydroxyanisole — and BHT — butylated hydroxytoluene — are synthetic phenolic antioxidants, and the word "phenolic" is doing real work here: both molecules are built around a phenol ring with bulky tert-butyl groups attached, a shape that lets them mop up the free radicals that start the chain reaction of fat oxidation. Food-grade BHA is a mixture of more than 85% 3-BHA and less than 15% 2-BHA; food-grade BHT is at least 99% pure. Both are white, waxy solids, insoluble in water but soluble in fats and oils, which is exactly the combination a fat preservative needs: they dissolve into the fat they are protecting and stay there. On food labels they appear as E320 and E321, and in cosmetics under the INCI names BHA and BHT.

The two are usually discussed as a pair because they do the same job, are often used together, and share a regulatory history — but they are not the same chemical, and their safety records diverge sharply, which is the thread this article follows. BHA has been added to edible fats and fat-containing foods since 1947, making it one of the oldest synthetic food additives still in use. BHT followed in the 1950s. Both are also used well outside food: in cosmetics and personal care products, in food packaging (where BHA stabilises petroleum-wax coatings), in animal feed, and in rubber and petroleum products. When you see BHA or BHT on a label, you are looking at an industrial antioxidant that happens to have a food use, not a food ingredient that happens to have industrial uses — and that history matters to how people feel about eating it, whatever the toxicology says.

Tip: Do not confuse BHA and BHT with the skincare acids that share similar initials. Cosmetic BHA (beta hydroxy acid, usually salicylic acid) is an exfoliant and has nothing to do with butylated hydroxyanisole; the two are different chemicals that happen to share an abbreviation. On a cosmetics ingredient list, "BHA" means the antioxidant butylated hydroxyanisole, while "salicylic acid" is the exfoliant — the context of the product tells you which world you are in.

Why they are used in food and cosmetics

Fats go bad, and they go bad in a specific way. Oxygen attacks the unsaturated fatty acids in oils and fats, producing free radicals that attack neighbouring molecules in a chain reaction; the result is rancidity — stale, paint-like smells, off flavours, and a loss of nutritional quality. An antioxidant interrupts that chain by donating a hydrogen atom to the free radical, stopping the reaction before it spreads. BHA and BHT are good at this, cheap, stable at cooking temperatures, and effective at very low concentrations — a combination that made them the default choice for mid-century food manufacturing, and a hard habit for the industry to break.

In food, that job is mostly about shelf life and logistics. A breakfast cereal, a packet of crisps, or a box of biscuits may sit in a warehouse, a truck, and a pantry for months; without an antioxidant, the fats in them would oxidise long before the best-before date. The same logic applies to the fats in processed meats, dry mixes, dehydrated potato products, and chewing gum. In cosmetics, the job is the same but the stakes are cosmetic: BHA and BHT stop the oils in a lipstick, cream, or lotion oxidising, which keeps the product's odour, colour, and texture stable over its shelf life. The US FDA's own 2026 announcement lists the foods where BHA turns up today — frozen meals, breakfast cereals, cookies, candy, ice cream, and meat products — and notes that while packaged-food label data show BHA use has declined in recent years, it remains present in many products, including ones marketed to children.

The reason manufacturers keep using them, rather than switching wholesale to the natural alternatives, is partly performance and partly inertia: the synthetic pair is predictable, works across a wide range of fats and temperatures, and costs little. The alternatives — vitamin E, rosemary extract, ascorbyl palmitate — work, and are already used in many products, but they behave differently in different fats, can cost more, and can bring their own flavours or colours. That trade-off is the commercial side of the story; the safety side is below.

Where you will find them

• Breakfast cereals and dry mixes — the classic BHA/BHT food: the US FDA caps both at 50 parts per million in dry breakfast cereals, and BHA at 90 parts per million in dry mixes for beverages and desserts
• Potato products — dehydrated potato shreds and potato flakes (50 parts per million for both), potato granules (10 parts per million), sweet potato flakes (50 parts per million)
• Chewing gum, baked goods, sweets, and snack foods — including crisps, crackers, and biscuits, where the fats would otherwise stale quickly on the shelf
• Fats, oils, and emulsion stabilisers for shortenings — both chemicals are capped at 200 parts per million in emulsion stabilisers for shortenings in the US; in Australia, the Food Standards Code caps BHA at 200 milligrams per kilogram in edible oils and BHT at 100
• Processed meats, sausage, and poultry products — where the fat content needs protection through processing and storage
• Active dry yeast and dry diced glazed fruit — niche uses where BHA alone is permitted at up to 1,000 and 32 parts per million respectively
• Cosmetics, above all lipstick — a 1981 FDA survey found BHA in 3,217 of 21,279 cosmetic formulations, most often in lipstick (1,256 of them); BHT is used in cosmetics at concentrations from 0.0002% to 0.8%
• Food packaging and animal feed — BHA stabilises petroleum-wax coatings on packaging and is permitted in packaging materials with a limit of 0.005% addition to food; both chemicals are used in animal feed

The concern: cancer, hormones, and the forestomach problem

The concern with BHA starts with cancer, and it starts in an organ you do not have. In long-term feeding studies, dietary BHA caused benign and malignant tumours of the forestomach — papillomas and squamous-cell carcinomas — in rats of both sexes and in male mice and hamsters. The forestomach is a storage pouch in front of the glandular stomach in rodents; humans have no equivalent structure, and neither do guinea pigs or dogs, which did not develop the tumours. The lesions appeared at high doses — proliferative changes at 2% of the diet in a 13-week study, with a no-effect level of 0.25% — and they largely regressed when BHA was withdrawn from the diet. The mechanism, as reviewers describe it, is not direct DNA damage: BHA is not DNA-reactive, and nearly all genotoxicity studies are negative. Instead, at high doses, BHA irritates the forestomach lining, driving cell proliferation, and the tumours arise from that chronic irritation and proliferation — a mechanism that is mostly reversible and, as the IARC itself later judged, not relevant to humans.

The cancer classifications are real, and they have never been withdrawn. The International Agency for Research on Cancer classified BHA as Group 2B — "possibly carcinogenic to humans" — in 1986, on the basis of sufficient evidence in experimental animals and inadequate evidence in humans. The IARC later determined that the forestomach mechanism is not relevant to humans, but the classification has not been revoked. The US National Toxicology Program lists BHA as "reasonably anticipated to be a human carcinogen", first listed in 1991 and still listed in the current edition — a listing the FDA's own February 2026 announcement quotes as part of its reason for reopening the file. California has listed BHA under Proposition 65 as a carcinogen since 1 January 1990, with a No Significant Risk Level of 4,000 micrograms per day (4 milligrams per day). Human evidence, meanwhile, is thin: the US National Toxicology Program's profile states that the available epidemiological studies are inadequate to evaluate the relationship between human cancer and BHA exposure specifically, and the one cohort study identified — Botterweck and colleagues' 2000 Netherlands Cohort Study — found no increase in stomach-cancer risk at typical levels of dietary BHA intake.

BHT's record is different, and in some ways more complicated. IARC places BHT in Group 3 — not classifiable as to its carcinogenicity to humans — on the basis of inadequate evidence in humans and inadequate or limited evidence in animals, and BHT is not on the National Toxicology Program's list or on Proposition 65. But BHT's animal story is not clean either: Europe's food safety authority found hepatocellular carcinomas in male rats, with a benchmark dose lower bound of 247 milligrams per kilogram of body weight per day, and concluded that any carcinogenicity would be thresholded — meaning there is a dose below which it does not occur — and that BHT is not a genotoxicity concern. High-dose animal studies have also linked BHT to liver toxicity and to the promotion of tumours in the liver, bladder, and lungs, and to developmental effects and thyroid changes — the thyroid, reproduction, and blood effects in rats are what set the older, lower acceptable daily intake. Curiously, BHT has also shown the opposite effect in some studies: at high doses above 3,000 parts per million, it inhibited the carcinogenicity of a variety of carcinogens in mice and rats. That contradiction — tumour promoter in one design, tumour inhibitor in another — is a fair summary of where BHT's evidence sits: real signals, no settled direction.

The endocrine question is unresolved for both. The European Commission's 2019 call for data on cosmetic ingredients with potential endocrine-disrupting properties put BHT in its higher-priority Group A and BHA in Group B. Europe's scientific committee then assessed both expressly considering endocrine concerns and deemed each safe at the stated cosmetic concentrations; the UK's advisory group found no clear evidence of endocrine activity for BHT, judging its thyroid effects likely secondary to liver toxicity. The primary literature is mixed: cell studies have reported both estrogenic and anti-estrogenic activity for BHA, and testicular effects in mouse testis cells, while other assays find no effect. Europe's food safety authority noted endocrine data gaps for BHA in 2011. None of this amounts to a finding that either chemical is an endocrine disruptor at the levels people are exposed to — and none of it amounts to a clean bill of health either. Both chemicals are detectable in human tissues: BHA has been found in breast milk, placenta, and adipose tissue, and BHT in cord blood, breast milk, serum, urine, and adipose tissue, which is why exposure, not just hazard, keeps coming up in the debate.

What regulators say

The United States permits both, within limits, and is now re-examining one of them. The FDA listed BHA as Generally Recognized as Safe in 1958 and approved it as a food additive in 1961; BHT was approved for food in 1954 and deemed Generally Recognized as Safe in 1959. The general ceiling is 0.02% of the fat or oil content of the food, with specific caps in the Code of Federal Regulations — 50 parts per million for both chemicals in dry breakfast cereals, 200 parts per million in emulsion stabilisers for shortenings, and, for BHA alone, up to 1,000 parts per million in active dry yeast. On 10 February 2026 the FDA launched a comprehensive re-assessment of BHA, considering whether it is safe under its current conditions of use in food and as a food-contact substance, based on the latest scientific information, with a request for information and a public docket; the FDA's commissioner said that once the BHA assessment is complete, similar assessments are expected for BHT and for azodicarbonamide. As of writing, that review has no outcome — BHA's legal status in the US has not changed.

Europe's position rests on two re-evaluations that both raised the safe intake, not lowered it. The European Food Safety Authority re-evaluated BHA in 2011 and set an acceptable daily intake of 1.0 milligrams per kilogram of body weight per day — double the 0.5 set by the Joint FAO/WHO Expert Committee on Food Additives and the EU's Scientific Committee on Food in 1989 — based on a no-effect level of 100 milligrams per kilogram per day in rats divided by an uncertainty factor of 100, and concluded that refined intake estimates for children and adults were unlikely to exceed it. It also concluded that BHA does not raise concern for genotoxicity, and that forestomach hyperplasia in rodents "may no longer be relevant for human risk assessment". For BHT, the 2012 re-evaluation set an acceptable daily intake of 0.25 milligrams per kilogram of body weight per day — five times the 0.05 set in 1987 — based on a no-effect level of 25 milligrams per kilogram per day in two-generation rat studies, again with no genotoxicity concern and thresholded carcinogenicity. Exposure is where the two diverge: adults were unlikely to exceed the BHT intake at the mean or the 95th percentile (worst-case estimates of 0.01–0.03 milligrams per kilogram per day at the mean, 0.03–0.17 at the 95th percentile), but children exceeded it at the 95th percentile in Finland and the Netherlands. For context, the older JECFA values were 0–0.5 for BHA (1989) and 0–0.3 for BHT (1996). European food law authorises both as additives under Regulation (EC) No 1333/2008, with category-by-category maxima set at the lowest level necessary, taking the acceptable daily intake and probable daily intake into account.

Australia and New Zealand set their own numbers in Schedule 15 of the Food Standards Code. The maximum permitted levels include BHA at 200 milligrams per kilogram in preparations of food additives and in edible oils, 1,000 milligrams per kilogram in flavourings, and 100 milligrams per kilogram in dried milk; BHT at 100 milligrams per kilogram in edible oils. The natural alternatives sit alongside them in the same Schedule: tocopherols and ascorbyl palmitate are permitted at good manufacturing practice levels — that is, only as much as needed for the technological purpose — and rosemary extract is capped at 50 milligrams per kilogram in edible oils and 75 in margarine. In cosmetics, the EU has already acted on BHT: following the scientific committee's 2021 opinion, Commission Regulation (EU) 2022/2195 restricts BHT to 0.001% in mouthwash, 0.1% in toothpaste, and 0.8% in other leave-on and rinse-off products. BHA has no legal cosmetics limit yet. In March 2026 the scientific committee advised that BHA is safe up to 0.07% in leave-on and rinse-off skin products, for dermal use only — not in oral-care products or products that could expose the lungs by inhalation — and a draft amendment would codify that figure. Until it is enacted, 0.07% is scientific advice, not law.

Two recent American developments show how unsettled the politics are. California's 2023 food-additive law, AB 418, is widely misreported as a BHA/BHT ban: it banned brominated vegetable oil, potassium bromate, propylparaben, and Red Dye 3, effective 1 January 2027, and did not cover BHA or BHT at all. West Virginia went further: HB 2354, signed in March 2025, bans BHA (along with propylparaben and seven dyes) in food sold in the state from 1 January 2028, with a school-meals ban from August 2025. But on 23 December 2025 a federal judge granted a preliminary injunction blocking enforcement of the 2028 sale-ban provisions, on the grounds that they were unconstitutionally vague; the school-meals provisions are unaffected. So the only US state ban on BHA currently exists on paper and cannot be enforced — a fact worth knowing before any article tells you BHA has been banned.

The debate

The position this site takes follows the dose and the person, not either slogan. The strongest case for action is for people who eat a lot of the foods that carry these chemicals — daily cereal, crisps, and processed snacks — and for children, whose high-end BHT intakes already exceed the European acceptable daily intake in some countries. For those people, the precautionary choice costs little: the same products increasingly exist with vitamin E or rosemary extract instead. The weakest case is for panic about a single serving: the evidence for harm at ordinary intakes is animal evidence at enormous doses, filtered through a mechanism humans largely lack, and every regulator that has re-examined these chemicals in the last fifteen years has kept them permitted. Watch the FDA's 2026 re-assessment — it is the first time in decades the US has reopened BHA on the merits, and its outcome matters more than any argument in this article. Until then, treat BHA and BHT as a reason to read labels and vary your diet, not as a reason to fear your breakfast.

Who should avoid them

• People who eat a lot of processed fatty foods every day — a daily bowl of preserved cereal, crisps, and processed snacks is the pattern that concentrates exposure to both chemicals; this is also the pattern where switching to products preserved with tocopherols or rosemary extract is easiest
• Parents choosing food for children — children's high-end BHT intakes exceed the European acceptable daily intake in some countries, and the FDA notes BHA remains in products marketed to children; children also eat more of the cereal and snack categories per kilogram of body weight
• People who prefer to minimise synthetic additives as a principle — BHA and BHT are both barred from certified organic foods in the US, so an organic or additive-minimal diet already avoids them without label-by-label checking
• People who use many BHT-containing cosmetics, especially lipstick — lipstick is the cosmetic category where BHA turns up most often, and lip products are partly ingested; the EU's cosmetics limits for BHT are lowest precisely for mouthwash and toothpaste, the products that go in the mouth
• Anyone in California reading a Proposition 65 warning — BHA's listing means some products carry a cancer warning for it; the warning reflects the listing and the 4-milligram-per-day safe-harbour level, not a measured risk from that product
• People who want to act ahead of the regulators — with the FDA's BHA re-assessment open and a European BHA cosmetics limit still in draft, anyone uncomfortable waiting for those outcomes can already choose the alternatives below

How to spot BHA and BHT on a label

BHA and BHT are easier to find on a label than most ingredients in this guide, because they have short names and E numbers — the difficulty is knowing which of the several names you are looking at. In food, the names to watch for are "butylated hydroxyanisole" and "butylated hydroxytoluene", the abbreviations BHA and BHT, and the E numbers E320 and E321. In Australia, they may also appear in the form "antioxidant (320)" or "antioxidant (321)", which is the same information in a different format. In cosmetics, the INCI names are simply BHA and BHT, usually near the end of the ingredient list — antioxidants are used in small amounts, so they sit late in the list, which is ordered by concentration.

• E320 / butylated hydroxyanisole / BHA — the same chemical under three names; if any of them appears, the product contains BHA
• E321 / butylated hydroxytoluene / BHT — the same for BHT; the two are often listed together as "antioxidants (320, 321)"
• "Antioxidant (320)" and "antioxidant (321)" — the Australian labelling format; the number is the E number without the E
• In cosmetics: BHA and BHT in the INCI list — check lipsticks, lip balms, creams, and lotions first, since these are the categories where they are used most
• What will not be on the label — BHA used in food packaging is not declared as an ingredient of the food, and neither is BHT in the packaging; the US allows BHA in packaging materials with a limit of 0.005% addition to the food, so a product can be exposed to BHA without the letters appearing anywhere on its label
• The "no BHA/BHT" claim and its replacements — products that have removed them often say so, and the replacements are usually declared as mixed tocopherols, vitamin E, rosemary extract, or ascorbyl palmitate; a product that says "no artificial preservatives" but lists tocopherols has swapped, not removed, its antioxidant

Related: Added Sugars: The Sweetener Hiding in Plain Sight — and Why the Numbers Disagree — the other half of the processed-food label: where this article is about what keeps a cereal from going stale, that one is about what makes it sweet, and why the world's agencies cannot agree on a number for it either.

Alternatives: what replaces them

The replacements for BHA and BHT are already on the market, and the three you will see most often are mixed tocopherols (vitamin E, E306–309), rosemary extract (E392), and ascorbyl palmitate (E304). Mixed tocopherols are the workhorse: they are vitamin E in its natural mixed form, they do the same free-radical-scavenging job, and they are already the stated preservative in products such as plain breakfast cereals that advertise "vitamin E (mixed tocopherols) added to preserve freshness". Rosemary extract, whose active compounds are carnosic acid and carnosol, has matched BHA and BHT in at least one published comparison in ground-beef patties, according to trade summaries of the study, and is used in products from kettle chips to spreads. Ascorbyl palmitate — a fat-soluble form of vitamin C — is usually used in combination with tocopherols, because the two work synergistically: the ascorbyl palmitate regenerates the tocopherol, extending its working life. All three are permitted in Australia at good manufacturing practice levels (tocopherols and ascorbyl palmitate) or at capped levels (rosemary extract, 50 milligrams per kilogram in edible oils), and in the EU tocopherols are permitted at quantum satis — as much as needed — while rosemary extract has category maxima.

The honest caveat is that none of the alternatives has BHA and BHT's decades of standardised performance data, and trade sources note they are typically used at higher concentrations (around 0.05–0.3%) and can behave differently in different fats — rosemary extract can bring flavour and colour, tocopherol efficacy depends on which form is used and how much. The third synthetic antioxidant, TBHQ (E319), is the usual industrial partner to BHA and BHT rather than a replacement for them, and BHA partly metabolises to TBHQ in the body, so switching from BHA to TBHQ is not the clean break it might look like. The simplest alternative of all needs no label at all: foods that are eaten fresh, or fats bought in small quantities and used quickly, do not need an antioxidant — the reason BHA and BHT exist is the long supply chain between factory and pantry, and shortening that chain, or buying smaller packs more often, removes the need for any of them.

Checked against the FDA's February 2026 BHA assessment announcement, EFSA's BHA (2011) and BHT (2012) re-evaluations, the US National Toxicology Program's Report on Carcinogens, SCCS opinions SCCS/1636/21 and SCCS/1682/25, and FSANZ Schedule 15 · Last updated 2026-11-06 · How we assess ingredients

Read more

Propylene Glycol: The Everywhere Humectant Behind the Allergy QuestionAdded Sugars: The Sweetener Hiding in Plain Sight — and Why the Numbers DisagreePhenoxyethanol: The Everyday Preservative Behind the Baby-Product Debate